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ABSTRACT 
Although essential hypertension (EHT) tends to coexist with other conditions, few studies have focused on 
comorbidities and symptoms among patients admitted to emergency departments (ED). The objective was to 
compare the characteristics, comorbidities and symptoms among patients with three types (unspecified, benign, or 
malignant) of EHT in Florida. A public use data set of ED patients from the Florida Agency for Health Care 
Administration (AHCA) from 2005 was used. Records included those with primary diagnosis of three types of EHT 
based on the International Classification of Diseases, 9th edition (ICD-9) code. Group comparisons were made 
using Chi square tests and linear regression models. Of 34,625 records, 96.3%, 2.0%, and 1.7% of them had 
unspecified, benign and malignant EHT, respectively. Types of EHT varied significantly (p < .05) by race/ethnicity, 
age group, health insurance status, discharge status, and length of stay. The most common secondary diagnoses 
included diabetes, abnormal lipid metabolism, hypokalemia, and anemia. Whereas diabetes without complication 
was the most common comorbidity of unspecified (10.7%) and malignant (12.6%) hypertensive patients, abnormal 
lipid metabolism was the most common co-morbidity of benign (20.0%) hypertensive patients. The most frequent 
symptom in all three groups was headache. About 60.0% (malignant), 34.6% (unspecified), and 4.2% (benign) of 
patients’ main reason for ED visit were not related to their principal diagnosis. Variation in factors contributing to 
comorbidities between three types of EHT should be further explored. 
Florida Public Health Review, 2008; 5, 84-92. 
 
Introduction 
High blood pressure (HBP) or hypertension (HT) 
is a risk factor for the two leading causes of death in 
the United States (US), heart disease and stroke.  
According to the Centers for Disease Control and 
Prevention (CDC), HBP continues to affect about one 
third of the US population (CDC, 2006).   Moreover, 
HT was responsible for 7.8 deaths per 100,000 
population in 2004 (CDC, 2004). Although there are 
several explanations for the high mortality and 
burden associated with HT, one possible reason may 
be due to the presence of multiple chronic conditions 
among hypertensive adults.  For example, 
comorbidities such as diabetes and chronic kidney 
disease have been associated with uncontrolled blood 
pressure (BP) (Trioli et al., 2004; Majernick et al., 
2004). Also, osteoarthritis and asthma have been 
detected in patients with HT (Wang et al., 2005).  
Hence, national and international HT management 
guidelines have recommended lower BP targets for 
individuals with target organ damage or other chronic 
conditions (Trioli et al., 2004). 
Whereas there is vast research on the prevalence, 
treatment, and control of HT, comorbidities 
associated with HT are relatively understudied.  
Conceivably, patients admitted to the emergency 
department (ED) in hospitals for HT may have 
greater levels of uncontrolled HT compared with the 
general population (Preston et al., 1999; Shayne & 
Pitts 2003; Karras et al., 2005). Patients admitted to 
the ED may present with conditions and symptoms 
not observed in other hypertensive adults who were 
not admitted to the ED. In addition, it is plausible that 
comorbidities and symptoms would vary by severity 
or subcategory of essential hypertension (EHT). 
Because the ED is likely to be the primary source of 
care for uninsured individuals, and uninsured 
hypertensive individuals have shown greater odds for 
uncontrolled BP, the ED provides a venue to assess 
hypertensive individuals with greater risk of HT 
complications (Tanabe et al., 2004; Duru et al., 
2007). Furthermore, because Florida is one of the 
leading states in the country with a multi-ethnic 
population, and the control of HBP has been shown 
to vary by race and ethnicity, research on the 
prevalence of comorbidities among HT patients 
admitted in a Florida ED is warranted (U.S. Census 
Bureau, 2000; Hajjar & Kotchen, 2003). This study 
would be beneficial for future prevention programs 
targeting groups at higher risk for complications 
related to EHT. To the authors’ knowledge, there are 
currently no published studies on comorbidity among 
individuals admitted in ED for EHT and its subtypes 
in Florida.  This study examined the demographic 
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and clinical characteristics of patients admitted to the 
ED with EHT in Florida.  Specifically, differences in 
comorbidities and symptoms between patients 
diagnosed with malignant, benign, and unspecified 




This study examined patients admitted with 
primary diagnosis of EHT in emergency departments 
(ED) of Florida hospitals in 2005. 
Setting 
The 2005 ED data from the Florida Agency for 
Health Care Administration (AHCA) were used. No 
personal identifiers appeared in the AHCA public use 
file. All patient records in 2005 that were verified by 
Florida hospitals and reported to AHCA by February 
2007 were included. Florida hospitals have up to 18 
months to check the accuracy of the data before 
sending the data to the AHCA. Therefore, the current 
data included all records of all Florida hospitals 
reported to the AHCA by February 2007.  
Sample 
Records with primary diagnosis of three sub-
categories of EHT based on the International 
Classification of Disease, 9th edition (ICD-9) code in 
2005 were extracted. Specifically, ICD-9 codes of 
401.0 or malignant EHT, 401.1 or benign EHT, and 
401.9 or unspecified EHT were included. Malignant 
EHT is defined as severe HT characterized by 
necrosis of the small arteries and swelling of the optic 
nerve or papilledema, with diastolic BP usually >130 
mm Hg, and target organ damage. Benign EHT is 
less severe than malignant EHT, without target organ 
damage and is usually symptomless. If the sub-
category of EHT is not specified, then it is coded as 
unspecified EHT (Medical Terminology Dictionary, 
2007; U.S. National Library of Medicine and 
National Institute of Health, 2007).  
Measures  
The main outcome measures included the chief 
reason for ED visit (complaint) and secondary 
diagnoses.  These variables were originally assigned 
based on the ICD-9 codes. Each record may have one 
primary diagnosis and up to nine secondary 
diagnoses. Two new variables relating to the 
symptoms of hypertension were created. Twelve 
related symptoms based on the ICD-9 codes included  
1) dizziness, 2) fatigue, 3) headache, 4) chest pain, 5) 
elevated blood pressure 6) nosebleed, 7) tachycardia, 
8) heart palpitations 9) unspecified, 10) blood in 
urine, 11) blurred vision, and 12) others. These 
symptoms were collapsed into a dichotomous 
variable as having one or more of the eleven 
symptoms (i.e., items 1 through 11 above) related to 
hypertension versus none of the symptoms or others 
(i.e., item 12). In addition, the reasons for ED visit 
was dichotomized as reasons related to the primary 
diagnosis (i.e., yes if malignant, benign, and 
unspecified EHT) versus reasons unrelated to the 
primary diagnosis or no.  A new variable that 
combined the reasons and symptom was then created; 
if the reasons or symptoms were related to the 
primary diagnosis, it was coded as yes or 1 and 
records with reasons or symptoms not related to the 
primary diagnosis was coded as no or 2. 
Socio-demographic variables included in the 
study were age, sex, race/ethnicity, and insurance 
status. Age groups were created from the original age 
variable as those < 25, 25-44, 45-64, 65-74, 75-84, 
and > 85 years. The original race/ethnicity code was 
categorized into four groups: 1) Blacks or African 
Americans, 2) non-Hispanic Whites, 3) Hispanics, 
and 4) others which included American 
Indians/Alaskan Natives, and Asians or Pacific 
Islanders. Insurance status was based on the original 
principal payer variable that contained 16 categories.  
These categories were collapsed into 5 categories: 1) 
Commercial [Health Maintenance Organization 
(HMO) and Preferred Provider Organization (PPO)], 
2) Federal (Medicare, Civilian Health and Medical 
Program of the Uniformed Services or Champus, and 
Veterans Administration or VA), 3) State (Medicaid, 
Workers Compensation, and other state/local 
government), 4) Charity and underinsured, and 5) 
others or uninsured (included those who did not have 
any of the above health insurance). The original 
discharge status included 10 categories which were 
collapsed into 3 categories: 1) discharged home (i.e., 
those discharged to home care or a home healthcare 
organization or discharged home on IV medications), 
2) expired, and 3) discharged to another facility (i.e., 
those transferred to a short term general hospital, to a 
skilled nursing facility, to an intermediate care 
facility, to another sub-category of institution or 
facility, and those that left against medical advice).  
Length of hospital stay was recoded as a categorical 
variable: less than one day versus one or more days.   
Data analysis 
Data analysis was performed using SPSS version 
14 (Chicago IL). Records with EHT were stratified as 
benign, malignant, and unspecified groups. Linear 
regression models were used to assess variations in 
hospital length of stay and age. Statistical tests (chi-
square and F tests) were used to evaluate differences 
in characteristics among EHT groups. 
 
Results 
Of the 5,546,999 ED records from the most 
recently updated 2005 AHCA data, 0.62% or 34,625 
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records had primary diagnosis of EHT. The mean and 
standard error (SE) of age were 59.3 (+0.68) years, 
61.7 (+ 0.58) years, and 57.6 (+ 0.09) years for 
patients with malignant, benign, and unspecified 
EHT, respectively (Data not shown). About 33,346 
(96.3%) records had unspecified HT, while only 701 
(2.0%) of records had benign and 578 (1.7%) had 
malignant EHT (Table 1). Patients were 
 
Table 1.  Emergency Department (ED) Records with Essential  
Hypertension in Florida, 2005 (n = 34,625) 
Essential Hypertension types & (ICD-9 code) n  % 
Malignant (401.0) 578 1.7 
Benign (401.1) 701 2.0 
Unspecified (401.9) 33346 96.3 
Sex#          
Male  13812 39.9 
Female 20812 60.1 
Race/Ethnicity##   
Black/African American 10644 31.4 
White 18960 55.9 
Hispanic 4040 11.9 
Others 244 0.8 
Age (years)   
<25 627 1.8 
25-44 7801 22.5 
45-64 13572 39.2 
65-74 5619 16.2 
75-84 5086 14.7 
>85 1920 5.6 
Discharge Status   
Discharged to Home 32899 95.5 
Discharged to another care facility 1724 4.5 
Expired 2 0 
Insurance Status###   
Commercial: HMO & PPO 9900 28.6 
Federal: Medicare etc 13162 38.0 
State: Medicaid etc 3154 9.1 
Underinsured & Charity 8342 24.1 
Uninsured 56 0.2 
Insurance Status###   
Commercial: HMO & PPO 9900 28.6 
Federal: Medicare etc 13162 38.0 
State: Medicaid etc 3154 9.1 
Underinsured & Charity 8342 24.1 
Uninsured 56 0.2 
Length of Stay   
< 1 day 28938 83.6 
> 1 day 5687 16.4 
# missing =1     ## missing = 737     ### missing = 11 
 
more likely to be female (60.1%), White (55.9%), 
discharged home (95.5%), and have a hospital stay 
<1 day (83.6%). About 38% had Medicare or other 
Federal health insurance; 24.1% were underinsured. 
There were no differences in gender distribution 
by three type of EHT (Table 2). There were 
statistically significant differences in race/ethnicity, 
age group, discharge status, insurance status, and 
length of stay between three types of EHT (p < .01).  
Most patients were White, female, and 45-64 years of 
age regardless of types of EHT. Less than one-third 
of patients had commercial health insurance. Over 
20% of patients with malignant and unspecified EHT 
were underinsured whereas 8% of patients with 
benign EHT were underinsured. There were only two 
deaths among patients with unspecified EHT. Length 
of stay of less than 1 day was more common among 
patients with benign EHT (98.3%) than unspecified 
(83.5%) or malignant (69.0%) EHT.  More patients 
with malignant (32.0%) EHT tended to stay longer 
during ED visits compared with unspecified (16.5%) 
and benign (1.7%) EHT patients.  
The most frequent secondary diagnosis among 
patients with malignant (12.6%) and unspecified 
(10.7%) EHT was diabetes without complications 
(Table 3). However, for benign EHT patients, the 
most frequent secondary diagnosis was abnormal 
lipid metabolism or lipid disorder (20.0%).  
Regardless of EHT type, diabetes and lipid 
metabolism disorders were the most frequent 
secondary diagnoses among patients admitted to the 
ED. When identifying the most frequent reason for 
visiting the ED with hypertension-related symptom, 
headache was found to be the most common among 
patients with malignant (6.6%), benign (0.4%), and 
unspecified (8.8%) EHT (Table 4). Interestingly, 
elevated blood pressure without prior diagnosis of 
hypertension (ICD-9 code 796.8) was also a frequent 
symptom among malignant (4.3%), benign (0.4%) 
and unspecified (5.7%) EHT. 
In assessing the congruence between principal 
diagnosis of EHT types and patients’ reason for ED 
visit, only 40% of malignant and 65.4% of 
unspecified EHT patients were able to identify their 
principal diagnosis EHT types correctly (p < .01) 
(Table 5). Most patients with benign (95.8%) EHT 
correctly identified their principal diagnosis as 
benign EHT. Thus, 60.0% patients with malignant 
EHT and 34.6% of patients with unspecified EHT as 
principal diagnoses were inconsistent with their 
reasons for ED visit diagnoses.  Moreover, malignant 
(74.6%) compared with unspecified (76.6%) benign 
(98.7%) EHT patients reported symptoms that were 
not related to EHT during their ED visits.
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Table 2: Variations in Patient Characteristics by Types of Essential Hypertension:  in Florida, 2005 (n = 34,625)  
             Essential Hypertension Types 
 
   Malignant 




  (n=33,346) 
 
  
    n ( %)   n (%)      n (%)     X2 P 
Sex# 
 
     4.749 a ns 
Male  
 
208 (36.0) 293 (41.8) 13311 (39.9)   
Female 
 
370 (64.0) 408 (58.2) 20034 (60.1)   
Race/Ethnicity## 
 













355 (63.62)  603 (87.0) 18002 (55.2)   
Hispanic 
 
63 (11.3) 4 (0.6) 3973 (12.2)   
Others 
 
1 (0.2) 1 (0.1) 242 (0.7)   
Age (years) 
 
   102.889 c ** 
<25 
 
3 (0.5) 9 (1.3) 615 (1.8)   
25-44 
 
117 (20.2) 99 (14.1) 7585 (22.8)   
45-64 
 
235 (40.7) 244 (34.8) 13093 (39.3)    
65-74 
 
102 (17.7) 196 (28.0) 5321 (16.0)   
75-84 
 
82 (14.2) 122 (17.4) 4882 (14.6)   
>85 
 
39 (06.7) 31 (4.4) 1850 (5.5)   
Discharge Status 
 
   31.408 d ** 
Discharged to Home 
 
549 (95.0) 698 (99.6) 31652 (94.9)   
Discharged to another care facility 
 
29 (5.0) 3 (0.4) 1692 (5.1)   
Expired 
 
0 (0.0) 0 (0.0) 2 (0.0)   
Insurance Status## 
 
   154.852 e ** 


































1 (0.2) 0 (0.0) 55 (0.1)   
Length of Stay 
 
   212.821a ** 
< 1 day 
 
393 (68.0) 689 (98.3) 27856 (83.5)   
> 1 day 
 
185 (32.0) 12 (1.7) 5490 (16.5)   
# missing = 1     ## missing= 737     ### missing =11 
a  2 degrees of freedom (df); b  6 df; c  10 df; d  4 df; e  8 df 
ns = not significant; * = p < .05; ** = p < .01 
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Table 3: The most frequent Secondary Diagnoses by types of Essential Hypertension in Florida, 2005  
            
Essential Hypertension Types 
 
  






Ranka Disease & (ICD-9)   n (%)   Disease & (ICD-9)   n (%)    Disease & (ICD-9)  n (%) 
1 Diabetes without 
complications 
(250.00)    
73  (12.6) Metabolism/ 
lipid disorder 
(272.4) 
  142 (20.0) Diabetes without 
complications 
(250.00)     
 3569 (10.7) 
2 Hypercholesterolemia 
(272.0) 
29 (5.1) Diabetes without 
complications 
(250.00)    
  112 (16.0) Hypercholesterolemia 
(272.0)      




       
  29 (5.1) Hypercholesterolemia 
(272.0)     
   87 (12.4) Metabolism/ 
lipid disorder 
(272.4) 
 595 (1.8) 
4 Hypokalemia (276.8) 
      
 23 (4.0) Obesity 
(278.0)  
    
52 (7.5) Hypokalemia (276.8) 
 
 565 (1.7) 
5 Obesity 
(278.0)  
            
   
10 (1.7) Anemia (285.9) 
 
          
26 (3.7) Disorder of the 









Comorbidities among individuals with EHT are 
understudied, possibly due to investigators using the 
presence of comorbidities as an exclusion criterion in 
studies (Fortin et al., 2006). Nevertheless, 
comorbidities are high in many populations such as 
the elderly and hypertensive adults (Wang et al., 
2005; Fortin et al., 2006; Fillenbaum et al., 2000). 
For example, Wang et al. (2005) indicated that at 
least 60% of the elderly population has multiple 
chronic conditions. Conditions often associated with 
HT in the general population include those related to 
cardiovascular risk, such as diabetes, obesity, and 
dyslipidemia (Majernick et al., 2004; Fortin et al., 
2006; Fillenbaum et al., 2000; Xu & Ragain, 2005; 
Nothwehr & Perkins, 2002). Due to the scarcity of 
studies relating to EHT-related comorbidities among 
ED patients, consistency of the findings with the 
current study cannot be evaluated. 
The findings from this study indicated that sub-
categories or types of EHT varied significantly by 
race and ethnicity, age group, discharge status, 
insurance status, and length of stay. Furthermore, 
frequencies of comorbidities varied by types of EHT.  
Diabetes was the most common secondary diagnosis 
in this study. It is plausible that patients with diabetes 
have greater levels of uncontrolled HBP leading to an 
ED visit. This finding is consistent with a study in 
which greater odds for uncontrolled HBP was found 
among ED patients with diabetes (Trioli et al., 2004).  
In contrast, heart failure, a risk factor for ED visit 
among hypertensive individuals, was not one of the 
most common secondary diagnoses in Florida ED 
patients (Tisdale et al., 2004).  It is likely that patients 
with heart failure in the current study were classified 
as having secondary HT and would not be included 
under primary or essential HT classification code. 
Prevalence of other co-existing conditions also 
differed by types of EHT. For instance, disorder of 
the urethra tract was common among patients with 
unspecified EHT while anemia was common among 
patients with benign EHT. Interestingly, Fortin et al. 
(2006) also found anemia to be a frequent diagnosis 
in about 10% of the non-hospitalized population with 
HT 
In terms of symptoms, headache was the most 
common complaint by patients with all three types of 
EHT.  Previous studies also have noted headache as a 
common complaint among ED patients (Marco et al., 
2007; Gaini et al., 2004; Zampaglione et al., 1996; 
Chiang & Jamshani., 1998). Along the same line, the 
most common symptoms reported in this study were 
also noted frequently in previous studies among ED 
patients with elevated BP (Preston et al., 1999; 
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Karras et al., 2005; Zampaglione et al., 1996). The 
symptomatology results also indicated that many 
hypertensive patients in this study were unaware that 
they had HT since they had elevated BP without 
previous diagnosis of HT as their reason for ED visit, 
particularly among patients with malignant EHT.  
This finding is surprising because diagnosis with 
malignant EHT implies complications due to elevated 
BP. Thus, it can be inferred that these patients did not 
receive the aggressive treatment that patients with 
malignant EHT would and should normally receive.  
It is also possible that their EHT condition was not 
diagnosed early enough or that a non-specific 
symptom such as headache was ignored during their 
visits to health care professionals. Furthermore, 
although HT has been termed “the silent killer” 
because of its lack of noticeable signs or symptoms, 
this study revealed that about one-fourth of patients 
with malignant or unspecified EHT reported HT 
related symptoms (e.g. headache, chest pain, fatigue) 
and those symptoms most frequent among EHT could 
be considered warning signs of elevated BP. This 
finding is consistent with a previous study where 
26% of patients with elevated BP presented 
symptoms such as chest pain, shortness of breath, 
headache, and nosebleed (Karras et al., 2005). 
Furthermore, patients with malignant EHT were 
less likely to have agreement between their primary 
diagnosis and their reason for ED visit. However, a 
higher percent of HT related symptoms was reported 
by patients with malignant EHT. These findings 
implied that individuals with malignant EHT may not 
only be more likely to have comorbidities and 
uncontrolled HT, but also lack knowledge about HT. 
This finding was supported by a study where lack of 
high BP knowledge was associated with poor BP 
control among ambulatory HT patients (Knight et al., 
2001). Not surprisingly, patients with malignant EHT 
were more likely to stay more than one day during 
ED visits than patients with benign or unspecified 
EHT. Differences observed between malignant and 
benign EHT in this study could partially be due a 
greater percentage of minorities (Blacks and 
Hispanics) representing with malignant EHT rather 
than benign EHT. For example, incidence of 
malignant HT has been shown higher among Blacks 
than Whites of hospitalized patients in the 
Netherlands (van den Born et al., 2006). Similarly, 
non-Hispanic Blacks and Hispanics have shown 
greater levels of uncontrolled HBP compared with 
non-Hispanic Whites in the general population 
(Hajjar & Kotchen, 2003). Among ED patients, 
African Americans have also been found to have 
greater BP levels compared with other ethnic groups 
(Karras et al., 2005). 
To our knowledge, this is the first study to 
explore comorbidities among ED-admitted patients 
with EHT in Florida. Strengths of this study were a 
large sample size and the validity of the data on 
comorbidities was greater compared to other studies 
relying on self-reported disease information. The 
accuracy of diagnoses in this study was enhanced by 
using the standard ICD-9 codes used by trained 
health personnel.  
Several limitations of this cross-sectional study 
should be noted. Primarily, there is the limitation in 
access to other patient characteristics such as 
measured BP value at ED admission, family history 
of other chronic conditions, length or chronicity of 
comorbid conditions, income, social support, use of 
antihypertensive medications, lifestyle habits (e.g. 
dietary and exercise), and frequency of ED visits.  
This study only included records with primary 
diagnosis of EHT, which are based on the primary 
service received in the ED. Thus, individuals with 
EHT that visited the ED primarily for reasons other 
than EHT were excluded. Since personal identifiers 
were not available, an individual that was admitted to 
ED more than once could not be identified.  The 
patient population was restricted to those visited ED 
only in 2005. Thus, patients with EHT who visited 
outpatient departments or inpatient acute-care 
hospitals were not included. 
 
Conclusion 
In summary, the most common comorbidities 
among ED patients with EHT were diabetes and 
metabolism lipid disorder, particularly among 
patients with malignant and unspecified EHT.  
Symptoms and signs such as headache and elevated 
BP were the most common and were mainly reported 
by patients with malignant or unspecified EHT.  
Patients with malignant EHT were more likely than 
patients with unspecified or benign EHT to be black 
or African American and provided a reason for ED 
visit inconsistent with the primary diagnosis type. 
Previous studies have shown an association of 
comorbidity with uncontrolled HBP among HT 
patients (Trioli et al., 2004; Preston et al., 1999; 
Shayne et al., 2003; Karras et al., 2005).  However,  it 
is not known if the ED patients with co-existing 
conditions and symptoms related to EHT in this study 
were unaware of or had uncontrolled HBP.  
Nevertheless, improved HT management and health 
education of HT related topics may be beneficial to 
the ED patients in Florida. Future studies should 
evaluate differences in presence of these conditions 
and symptoms by various patient characteristics 
among hypertensive patients, particularly differences 
by race/ethnicity.  
6
Florida Public Health Review, Vol. 5 [2008], Art. 13
https://digitalcommons.unf.edu/fphr/vol5/iss1/13
 






The findings from this study have the important 
implications for both medical and public health 
professionals interested in the prevention and control 
of hypertension and related complications. Few 
studies have focused on comorbidities and symptoms 
among patients admitted to emergency departments 
(ED) with EHT, yet identifying comorbidities may 
influence the management of hypertension. Based on 
our results, conditions most likely to coexist with 
EHT among Florida patients included diabetes and 
lipid metabolism disorder. Conceivably, management 
of EHT may be improved if these coexisting chronic 
diseases are detected and controlled early. Prevention 
programs and interventions that educate individuals 
about symptoms associated with hypertension may 
not only increase awareness of high blood pressure, 
but may also increase awareness of when 






Table 4:  The most frequent Reason (patients’ complaint) for ED by types of Essential Hypertension in Florida, 2005  
           
Essential Hypertension Types 
  






Ranka Reason &  
(ICD-9) 
  n (%)   Reason &  
(ICD-9) 
  N (%)  Reason &  
(ICD-9) 
 n (%) 
1 Headache  
(780.0) 
38 (6.6) Headache  
(780.0)   
 
 3 (0.4) Headache  
(780.0)  
 
 2954 (8.8) 
2 Chest pain 
(786.50) 
 
 36 (6.2) Elevated BP without 
hypertension 
(796.2) 
 3 (0.4) Elevated BP without 
hypertension 




 26  (4.5)       Dizziness 
(780.4) 




 628 (1.8) 
4 Elevated BP without 
hypertension 
(796.2) 
  25 (4.3) Chest pain 
(786.50)    
 1 (0.1) Fatigue 
(780.79) 
 449 (1.3) 
5 Fatigue 
(780.79) 
 10 (1.7) NA b 
 
         
  Palpitations 
(785.1)  
  156 (0.4) 
a Rank is based on frequency of a primary reason ICD-9 code. b Only 4 symptoms related to Benign EHT.  Thus, 5th rank symptom is NA. 
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Table 5:  Comparison between Principal Diagnosis and Patients’ Reason for Emergency Department (ED) Visit  
           









       n (%) n (%)       N (%)       X2 p 
Reason for ED visit based on 
EHT Type 
 








   231 (40.0)     0     ( 0)          5   (0.0)    
401.1: Benign 
 
      5 ( 0.86) 672 (95.8)         3   (0.0)   
401.9: Unspecified 
 
 120 (20.76)   13 ( 1.9) 21786 (65.4)   
Other 
 
 222 (38.38)   16 ( 2.3) 11552 (34.6)   
Reason for ED visit based on 
symptoms related to EHT 
 










 147 (25.4)    9   ( 1.3) 7814   (23.4)   
No 
 
 431 (74.6) 692 (98.7) 25532 (76.6)   
Reason for ED visit based on 
types of or symptoms related to 
EHT 
 










503 (87.0) 694 (99.0) 29608 (88.8)   
No 75 (13.0) 7 (1.0) 3738 (11.20)   
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